Total Payments
$58,222
2024 Payments
$175.50
Companies
17
Transactions
125
Medicare Patients
2,980
Medicare Billing
$414,719
Payment Breakdown by Category
Other$39,602 (68.0%)
Travel$10,160 (17.5%)
Consulting$5,000 (8.6%)
Food & Beverage$3,459 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,603 | 12 | 68.0% |
| Travel and Lodging | $10,160 | 36 | 17.5% |
| Consulting Fee | $5,000 | 2 | 8.6% |
| Food and Beverage | $3,459 | 75 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $56,781 | 80 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.85 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $193.60 | 12 | $0 (2023) |
| Allergan Inc. | $176.67 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $167.83 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $160.21 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $116.68 | 2 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $106.52 | 5 | $0 (2024) |
| Medtronic USA, Inc. | $80.73 | 1 | $0 (2018) |
| Novo Nordisk Inc | $60.83 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.50 | 9 | Novo Nordisk Inc ($60.83) |
| 2023 | $247.63 | 13 | Merck Sharp & Dohme LLC ($128.42) |
| 2022 | $121.73 | 7 | Merck Sharp & Dohme LLC ($65.18) |
| 2021 | $114.13 | 2 | SANOFI-AVENTIS U.S. LLC ($99.69) |
| 2019 | $64.88 | 4 | Janssen Pharmaceuticals, Inc ($19.96) |
| 2018 | $9,939 | 10 | Daiichi Sankyo Inc. ($9,718) |
| 2017 | $47,559 | 80 | Daiichi Sankyo Inc. ($47,063) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Gastroenterology | ||||||
| 01/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Bone Health | ||||||
| 10/09/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $43.36 | General |
| Category: Heart Failure | ||||||
| 10/03/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/15/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Bone Health | ||||||
| 08/10/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/30/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/17/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 803 | 1,514 | $301,044 | $121,550 |
| 2022 | 12 | 715 | 1,041 | $245,156 | $86,046 |
| 2021 | 6 | 640 | 1,022 | $265,200 | $91,347 |
| 2020 | 7 | 822 | 1,246 | $368,447 | $115,775 |
Total Patients
2,980
Total Services
4,823
Medicare Billing
$414,719
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 511 | $108,843 | $44,306 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 330 | $47,520 | $21,165 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 73 | $20,878 | $9,524 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $23,944 | $8,561 | 35.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 26 | 111 | $20,091 | $8,553 | 42.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 35 | 92 | $16,652 | $7,047 | 42.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 29 | 34 | $11,424 | $4,699 | 41.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 54 | 68 | $11,820 | $4,039 | 34.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 23 | 29 | $9,744 | $3,654 | 37.5% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 17 | 62 | $10,602 | $3,432 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,135 | $2,414 | 39.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 37 | 53 | $7,526 | $1,788 | 23.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 12 | 22 | $3,036 | $1,237 | 40.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 18 | $2,484 | $913.42 | 36.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 23 | $345.00 | $218.96 | 63.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 239 | $50,907 | $23,294 | 45.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 122 | 221 | $45,017 | $14,353 | 31.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 86 | 98 | $37,248 | $11,719 | 31.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 110 | 186 | $37,824 | $10,186 | 26.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 61 | 72 | $27,378 | $8,953 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 60 | $8,640 | $4,153 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,840 | $3,832 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 16 | $4,576 | $2,209 | 48.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 23 | 27 | $5,895 | $1,757 | 29.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 14 | 14 | $4,178 | $1,392 | 33.3% |
About Dr. Amish Patel, MD
Dr. Amish Patel, MD is a Family Medicine healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932384955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amish Patel, MD has received a total of $58,222 in payments from pharmaceutical and medical device companies, with $175.50 received in 2024. These payments were reported across 125 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,603).
As a Medicare-enrolled provider, Patel has provided services to 2,980 Medicare beneficiaries, totaling 4,823 services with total Medicare billing of $414,719. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine
- Location Raleigh, NC
- Active Since 01/09/2008
- Last Updated 09/01/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932384955
Products in Payments
- Movantik (Drug) $38,633
- Morphabond ER (Drug) $14,050
- CL-108 (Drug) $4,098
- AVYCAZ (Drug) $176.67
- ENTRESTO (Drug) $167.83
- XARELTO (Drug) $160.21
- JARDIANCE (Drug) $156.82
- VERQUVO (Drug) $133.46
- NUPLAZID (Drug) $106.52
- KYPHON Balloon Kyphoplasty (Device) $80.73
- BELSOMRA (Drug) $60.14
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $43.36
- Ozempic (Drug) $38.93
- PRADAXA (Drug) $34.40
- EVENITY (Biological) $27.63
- Rybelsus (Drug) $21.90
- XIFAXAN (Drug) $21.03
- EXPAREL (Drug) $20.23
- SOLIQUA 100/33 (Biological) $16.99
- ELIQUIS (Drug) $16.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Raleigh
William Cromwell, M.d, M.D
Family Medicine — Payments: $1.4M
Family Medicine $1.4M
Scott Brundle, Md, MD
Family Medicine — Payments: $29,978
Family Medicine $29,978
John Burkard, M.d, M.D
Family Medicine — Payments: $24,130
Family Medicine $24,130
Dr. Mohammad Baloch, Md, MD
Family Medicine — Payments: $20,034
Family Medicine $20,034
Kristina Kohuth, Pa-C, PA-C
Family Medicine — Payments: $18,377
Family Medicine $18,377
Anu Bommareddi, M.d, M.D
Family Medicine — Payments: $14,082
Family Medicine $14,082